Five guys.

European consensus is to adopt short-course radiation for rectal cancer in almost any scenario that calls for radiation at all. In case you’re curious, the GI team at MSKCC agrees. They are currently mandating short-course regimens for all localized rectal cancer cases. Because, well, in these times it’s sort of a no-brainer with no virtually no increased risk in cancer outcomes while affording a 5-for-1 deal in the number of patients on treatment for the resources / exposure price of one long-course treatment. | Romesser, Adv Radiat Oncol 2020